3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
37
Neoplasms, Plasma Cell
11
Recurrence
6
Lymphoma, Mantle-Cell
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Peripheral Nervous System Diseases
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Immunoglobulin Light-chain Amyloidosis
2
Glioblastoma
2
Waldenstrom Macroglobulinemia
1
Renal Insufficiency
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Paraproteinemias
1
Pancreatic Neoplasms
1
Ovarian Neoplasm Epithelial
1
Neoplasms by Histologic Type
1
Neoplasms
1
Neoplasm, Residual
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Plasma Cell
1
Leukemia
1
Hypoxia
1
Interventions
Tretinoin
11
Arsenic Trioxide
7
Idarubicin
4
Mitoxantrone
3
Etoposide
3
Daunorubicin
3
Cytarabine
3
Thioguanine
2
Radiotherapy
2
Cyclophosphamide
2
sargramostim
1
Watchful Waiting
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Mercaptopurine
1
Hydroxyurea
1
Filgrastim
1
Busulfan
1
Bortezomib
1
Ascorbic Acid
1
Amsacrine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Leukemia, Promyelocytic, Acute
×
Bortezomib
×
Clear all
NCT01950611
2013-09-25
PIAPL
Christian Medical College, Vellore, India
Phase 2
Unknown
30 enrolled